期刊文献+

麻痹性痴呆与阿尔茨海默病患者海马区氢质子磁共振波谱特点 被引量:8

Hydrogen proton magnetic resonance spectroscopy of hippocampus of patients with general paresis of insane and Alzheimer's disease
原文传递
导出
摘要 目的 应用氢质子磁共振波谱(1 H-MRS)技术,探索麻痹性痴呆(GPI)患者、阿尔茨海默病(AD)患者和健康中老年人海马区代谢物水平特点.方法 纳入GPI患者35例,AD患者27例,健康中老年对照38名进行双侧海马区1 H-MRS检查,比较N-乙酰天门冬氨酸(N-acetylaspartate,NAA)/肌酸、胆碱/肌酸,NAA/胆碱,胆碱/NAA和肌醇/肌酸的水平;并同日进行简易精神状态检查(MMSE)、蒙特利尔认知检查量表(MoCA)评定,探索GPI、AD患者海马区代谢物水平与病程严重程度的相关性.结果 GPI、AD组双侧海马区的NAA/肌酸均显著低于健康对照组(左侧1.48 ±0.25、1.52±0.28和1.71 ±0.36,F=5.928,P=0.004;右侧 1.47±0.38、1.62±0.36和1.82±0.42,F=7.309,P=0.001),GPI组右侧海马区的胆碱/NAA (0.68±0.48)显著高于AD组(0.49 ±0.15)和健康对照组(0.53±0.14),差异有统计学意义(P =0.024,P=0.045).GPI组和AD组海马区各代谢物水平与MMSE、MoCA评分均无显著相关.结论 GH和AD患者均存在双侧海马区神经元损伤. Objective To investigate the characteristics of hydrogen proton magnetic resonance spectroscopy (1H-MRS) in bilateral hippocampus in patients with general paresis of insane (GPI) and Alzheimer's disease (AD).Methods The metabolic ratios of N-acetylaspartate/creatine (NAA/Cr),choline (Cho)/Cr,NAA/Cho,Cho/NAA and myo-inositol (mI)/Cr in bilateral hippocampus were determined by 1 H-MRS in 35 patients with GPI,27 patients with AD and 38 normal controls (NC),and the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment scale (MoCA) scores were evaluated on the same day.Results The NAA/Cr in bilateral hippocampus of patients with GPI and AD was significantly lower than that of the NC (left:1.48 ± 0.25,1.52 ± 0.28 and 1.71 ± 0.36,F =5.928,P =0.004;right:1.47 ±0.38,1.62 ±0.36 and 1.82 ±0.42,F =7.309,P =0.001).The Cho/NAA in right hippocampus of patients with GPI (0.68 ± 0.48) was significantly higher than that of the AD patients (0.49 ± 0.15) and NC (0.53 ± 0.14,P =0.024,P =0.045).There was no significant correlation between the metabolic ratios in bilateral hippocampus of patients with GPI and AD and the scores of MMSE and MoCA.Conclusion Patients with GPI and AD have neuronal dysfunction in bilateral hippocampus.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2015年第1期36-39,共4页 Chinese Journal of Neurology
基金 广东省科技计划项目(2010B060900095) 广州市医药卫生科技项目(2012A011070019)
关键词 神经梅毒 阿尔茨海默病 海马 磁共振波谱学 Neurosyphilis Alzheimer disease Hippocampus Magnetic resonance spectroscopy
  • 相关文献

参考文献13

  • 1Marra CM. Update on neurosyphilis[J]. Curr Infect Dis Rep, 2009, 11(2): 127-134.
  • 2WangJ, Guo Q, Zhou P, et al. Cognitive impairment in mild general paresis of the insane: AD-like pattem[J]. Dement Geriatr Cogn Disord, 2011,31(4): 284-290.
  • 3Kodama K, Okada S, Komatsu N, et al, Relationship between MRI findings and prognosis for patients with general paresis[lJ.J Neuropsychiatry Clin Neurosci, 2000, 12(2): 246-250.
  • 4Ackl N, Ising M, Schreiber Y A, et al. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer' s disease. Neurosci Lett, 2005, 384( 1-2): 23-28.
  • 5Dixon RM, Bradley KM, Budge MM, et al. Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease[J}. Brain, 2002, 125 ( Pt 10) : 2332-2341.
  • 6Dubois B, Feldman HH,Jacova C, et al. Research criteria for the diagnosis of Alzheimer' s disease: revising the NINCDSADRDA criteriaj L], Lancet Neurol, 2007,6(8): 734-746.
  • 7Zhong XM, Hou L, Luo XN, et at. Alterations of CSF cystatin C levels and their correlations with CSF A1340 and Aj342 levels in patients with Alzheimer's disease, dementia with lewy bodies and the atrophic form of general paresis]J]. PLoS One, 2013, 8 (1 ) : e55328.
  • 8张全贵,张宁男楠.阿尔茨海默病的氢离子磁共振波谱特征[J].中外医学研究,2011,9(23):125-126. 被引量:5
  • 9Foy CM, Daly EM, Glover A, et al. Hippocampal proton MR spectroscopy in early Alzheimer' s disease and mild cognitive impairmentJ J]. Brain Topogr, 2011,24(34): 316-322.
  • 10冯逢.氢质子磁共振波谱在阿尔茨海默病临床研究中的进展[J].中国现代神经疾病杂志,2011,11(3):275-279. 被引量:2

二级参考文献60

  • 1李玉华,张忠阳,殷胜利.正常成人和阿尔茨海默病的扣带回后部质子磁共振频谱研究[J].中国医学影像技术,2006,22(1):64-66. 被引量:18
  • 2郑东,宁玉萍,邓少玲.麻痹性痴呆36例临床分析[J].广州医药,2006,37(4):10-12. 被引量:5
  • 3Atlas SW. Magnetic resonance imaging of the brain and spine. 3rd edition. New York:Philadelphia Lippincott Williams and Wilkins, 2002 : 1189.
  • 4Waldman AD, Rai GS, McConnell JR, et al. Clinical brain proton magnetic resonance spectroscopy for management of Alzheimer's and sub-cortical ischemic vascular dementia in older people. Arch Gerontol Geriatr, 2002, 35: 137-142.
  • 5Vogt BA, Finch DM, Olson CK. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cerebral Cortex, 1992, 2: 435-443.
  • 6Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology, 2001, 56: 592-598.
  • 7Krishnan KR, Charles HC, Doraiswamy PM, et al. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatry, 2003, 160 : 2003-2011.
  • 8Kantarci K, Reynolds G, Petersen RC, et al. Proton MR spectroscopy in mild cognitive impairment and Alzheimer' s disease : comparison of 1.5T and 3T. AJNR, 2003, 24:843-849.
  • 9Kantarci K, Smith GE, Ivnik RJ, et al. 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in norm al aging, mild cognitive impairment and Alzheimer' s disease. J Int Neurepsychol Soc, 2002, 8: 934-942.
  • 10Waldman AD, Bai GS. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study. Neuroradiology, 2003, 45: 507- 512.

共引文献26

同被引文献75

引证文献8

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部